163 related articles for article (PubMed ID: 27722500)
41. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
[TBL] [Abstract][Full Text] [Related]
42. The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium - Possible consequences for the medical application.
Chałubiński M; Szulc A; Gorzelak-Pabiś P; Wojdan K; Appelhans D; Bryszewska M; Broncel M
Vascul Pharmacol; 2022 Apr; 143():106972. PubMed ID: 35176515
[No Abstract] [Full Text] [Related]
43. Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.
Aso E; Martinsson I; Appelhans D; Effenberg C; Benseny-Cases N; Cladera J; Gouras G; Ferrer I; Klementieva O
Nanomedicine; 2019 Apr; 17():198-209. PubMed ID: 30708052
[TBL] [Abstract][Full Text] [Related]
44. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
45. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
46. Combined EPR and molecular modeling study of PPI dendrimers interacting with copper ions: effect of generation and maltose decoration.
Furlan S; La Penna G; Appelhans D; Cangiotti M; Ottaviani MF; Danani A
J Phys Chem B; 2014 Oct; 118(42):12098-111. PubMed ID: 25247928
[TBL] [Abstract][Full Text] [Related]
47. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.
de Vries A; Moonen R; Yildirim M; Langereis S; Lamerichs R; Pikkemaat JA; Baroni S; Terreno E; Nicolay K; Strijkers GJ; Grüll H
Contrast Media Mol Imaging; 2014; 9(1):83-91. PubMed ID: 24470297
[TBL] [Abstract][Full Text] [Related]
48. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.
Birdhariya B; Kesharwani P; Jain NK
Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759
[TBL] [Abstract][Full Text] [Related]
49. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
50. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
[TBL] [Abstract][Full Text] [Related]
51. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Brewster M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW
J Drug Target; 2006 Feb; 14(2):69-86. PubMed ID: 16608734
[TBL] [Abstract][Full Text] [Related]
52. Gadolinium-Labeled Biodegradable Dendron-Hyaluronic Acid Hybrid and Its Subsequent Application as a Safe and Efficient Magnetic Resonance Imaging Contrast Agent.
Guo C; Sun L; Cai H; Duan Z; Zhang S; Gong Q; Luo K; Gu Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):23508-23519. PubMed ID: 28656751
[TBL] [Abstract][Full Text] [Related]
53. Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer.
Gizzatov A; Stigliano C; Ananta JS; Sethi R; Xu R; Guven A; Ramirez M; Shen H; Sood A; Ferrari M; Wilson LJ; Liu X; Decuzzi P
Cancer Lett; 2014 Sep; 352(1):97-101. PubMed ID: 24931336
[TBL] [Abstract][Full Text] [Related]
54. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.
Trivedi ER; Ma Z; Waters EA; Macrenaris KW; Subramanian R; Barrett AG; Meade TJ; Hoffman BM
Contrast Media Mol Imaging; 2014; 9(4):313-22. PubMed ID: 24706615
[TBL] [Abstract][Full Text] [Related]
56. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
57. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
[TBL] [Abstract][Full Text] [Related]
58. Fabrication of Gd/Eu-codoped SmPO4 nanorods for dual-modal magnetic resonance and bio-optical imaging.
Wu Z; Huang Z; Yin G; Wang L; Gao F
J Colloid Interface Sci; 2016 Mar; 466():1-11. PubMed ID: 26692538
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK
Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482
[TBL] [Abstract][Full Text] [Related]
60. Dendritic PARACEST contrast agents for magnetic resonance imaging.
Pikkemaat JA; Wegh RT; Lamerichs R; van de Molengraaf RA; Langereis S; Burdinski D; Raymond AY; Janssen HM; de Waal BF; Willard NP; Meijer EW; Grüll H
Contrast Media Mol Imaging; 2007; 2(5):229-39. PubMed ID: 17937448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
